Showing 681-690 of 2105 results for "".
Vascular Cognitive Impairment, Part 2
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment-part-2/30582/Cognitive impairment after acute stroke is likely under-appreciated despite its impact.Infectious Causes of Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/infectious-causes-of-stroke/31616/Stroke is an often-devastating and not uncommon complication of many central nervous system infections.Stroke Patient Rehabilitation
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-patient-rehabilitation/30298/A guide to simplify stroke patient dispositions.Sleep, Sleeplessness, & Neuropsychiatric Conditions
https://practicalneurology.com/diseases-diagnoses/sleep/sleep-sleeplessnes--neuropsychiatric-conditions/30111/Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.Benefits of PFO Closure Confirmed in Publication of Trial Data
https://practicalneurology.com/diseases-diagnoses/stroke/benefits-of-pfo-closure-confirmed-in-publication-of-trial-data/30310/Cryptogenic Stroke & Atrial Fibrillation: Establishing the Link Through Team Approaches to Care
https://practicalneurology.com/diseases-diagnoses/stroke/cryptogenic-stroke--atrial-fibrillation-establishing-the-link-through-team-approaches-to-care/30393/Implementing a Cryptogenic Stroke Pathway may help reduce recurrent strokes and improve outcomes for stroke patients.Multiple Sclerosis and COVID-19
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-and-covid-19/31725/Understanding the immune system, drug proposed mechanisms of action, and considerations for care during COVID-19.Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/care-of-individuals-with-neurofibromatosis-type-1-amid-an-evolving-paradigm-of-therapeutic-development/35583/Treatment for individuals with neurofibromatosis type 1, a complex disease with variabilities in presentation and disease course, requires a multidisciplinary approach with emphasis on surveillance along with ongoing discussion of therapeutic interventions.New Directions in the Management of Focal Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/new-directions-in-the-management-of-focal-epilepsy/30431/Lewy Body Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/lewy-body-dementia/30167/The second most prevalent form of dementia has effective symptomatic treatments available.